Article: VaxGen to Hold Webcast and Conference Call to Review Smallpox Vaccine Data.

BRISBANE, Calif., May 25 /PRNewswire-FirstCall/ --

 
   WHAT: Cyril Empig, Associate Director, Virology of VaxGen, Inc. 
 , will review results from two animal studies of 
 the effectiveness of its attenuated smallpox vaccine candidate, 
 LC16m8.  These results are scheduled to be presented at the 
 Seventh Annual Conference on Vaccine Research sponsored by the 
 National Foundation for Infectious Diseases (NFID) on May 26th. 
 In addition to its smallpox vaccine candidate, VaxGen is 
 developing an anthrax vaccine candidate under contract with the 
 U.S. government. 
 
   ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!